HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aesthetic Medicine

1,406.842

-59.130-4.03%

Number of Gainers:2

Number of Losers:8

Number of Flat:3

PE:- -

High:1,484.120

Open:1,465.273

Low:1,402.205

Close:1,465.971

Volume:47.03M

Turnover:934.94M

Market Cap:232.72B

Float Cap:170.67B

Loading ...

Modern Dental (03600) Reports Interim Results with Shareholder Attributable Profit of HK$285 Million, Up 32.52% Year-on-Year

BRIEF-Modern Dental Group Posts H1 Net Income HKD288.7 Million

BRIEF-China Medical System Receives Approval For Clinical Trials Of Jak1 Inhibitor POVORCITINIB

Modern Dental Group Ltd. Announces Interim Dividend of HKD 0.107 Per Share

Modern Dental Group H1 Gross Margin 54.8%

THOMSON REUTERS

Modern Dental Group Ltd - Declared Interim Dividend of HK10.7 Cents per Share

THOMSON REUTERS

Modern Dental Group H1 Adjusted Ebitda Margin 24.9%

THOMSON REUTERS

CMS (00867): Innovative Oral Small Molecule JAK1 Inhibitor Povorcitinib Receives Clinical Trial Approval for Vitiligo and Hidradenitis Suppurativa Indications

China Medical System Holdings Limited Approval of Clinical Trials for Vitiligo and Hidradenitis Suppurativa Indications of Povorcitinib

THOMSON REUTERS

Dermavon Holdings, a Subsidiary of China Medical System, Gains Approval for Clinical Trials on Innovative JAK1 Inhibitor

China Medical System Holdings Ltd - Nmpa Approves Clinical Trials for Povorcitinib

THOMSON REUTERS

JPMorgan Increases Holdings in ANGELALIGN (06699) by 493,200 Shares at Approximately HK$67.58 Per Share

China Merchants Bank International Raises ANGELALIGN (06699) Target Price to HK$86.47, Overseas Business Expansion Drives Revenue Growth, Maintains "Buy" Rating

Hong Kong Stock Alert | FOSUN PHARMA (02196) Surges Nearly 5% in Early Trading as Interim Net Profit Jumps Nearly 40% YoY, Grants Overseas Development Rights to Sitala

LAI FUNG HOLD (01125) Shareholders Transfer Shares from ICBC Asia Securities to Bank of China (Hong Kong), Transfer Value Reaches HK$32.18 Million

Goldman Sachs Raises ANGELALIGN (06699) Target Price to HK$81.3 with "Buy" Rating

FOSUN PHARMA (02196): Drug Registration Application for Vincristine Sulfate Injection Accepted by National Medical Products Administration

Press Release: Fosun Pharma Announces 2025 Interim Results

FOSUN PHARMA (02196) Reports 2025 Interim Results with Improved Operating Cash Flow and Continued Innovation Transformation

AH Stock Statistics | August 26

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK1593/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"Aesthetic Medicine","latestPrice":1406.8418,"timestamp":1757473305529,"preClose":1465.9714,"halted":0,"volume":47032182,"delay":0,"changeRate":-0.040335,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-59.129639,"latestTime":"09-10 11:01:46","open":1465.2734,"high":1484.1199,"low":1402.2052,"amount":934937430,"amplitude":0.055877,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1757476800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1757467800000,1757476800000],[1757480400000,1757491200000]],"pbRate":2.102569,"peRate":29.549589,"turnoverRate":0.002359,"increases":2,"decrements":8,"flats":3,"marketCap":232718658760,"floatMarketCap":170673742920},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":1484.1199,"amplitude":0.055877,"preClose":1465.9714,"low":1402.2052,"pbRate":"2.102569","latestPrice":1406.8418,"volume":47032182,"delay":0,"open":1465.2734,"prevYearClose":571.87146,"prevWeekClose":1420.862,"prevMonthClose":1253.623,"prevQuarterClose":1037.486,"fiveDayClose":1340.928,"twentyDayClose":1287.754,"sixtyDayClose":980.122,"secType":"PLATE","market":"HK","turnoverRate":0.002359,"peRate":29.549589,"marketCap":232718658760,"floatMarketCap":170673742920,"timestamp":1757473305529,"nameCN":"Aesthetic Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":2,"down":8,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1177701158","title":"Modern Dental (03600) Reports Interim Results with Shareholder Attributable Profit of HK$285 Million, Up 32.52% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1177701158","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177701158?lang=en_us&edition=fundamental","pubTime":"2025-08-28 23:36","pubTimestamp":1756395379,"startTime":"0","endTime":"0","summary":"Modern Dental (03600) announced its interim results for the six months ended June 30, 2025. The group achieved revenue of HK$1.835 billion, representing a 7.81% year-on-year increase. Profit...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1593","03600","BK1583"],"gpt_icon":0},{"id":"2562059602","title":"BRIEF-Modern Dental Group Posts H1 Net Income HKD288.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2562059602","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562059602?lang=en_us&edition=fundamental","pubTime":"2025-08-28 23:00","pubTimestamp":1756393258,"startTime":"0","endTime":"0","summary":"BRIEF-Modern Dental Group Posts H1 Net Income HKD288.7 MillionAug 28  - Modern Dental Group Ltd 3600.HK:H1 GROSS MARGIN 54.8%H1 ADJUSTED EBITDA MARGIN 24.9%DECLARED INTERIM DIVIDEND OF HK10.7 CENTS PER SHAREH1 NET INCOME HKD 288.7 MILLIONH1 REVENUE HKD 1,834.8 MILLIONFurther company coverage: 3600.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nPLX49C22D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1593","03600","BK1583"],"gpt_icon":0},{"id":"2562059620","title":"BRIEF-China Medical System Receives Approval For Clinical Trials Of Jak1 Inhibitor POVORCITINIB","url":"https://stock-news.laohu8.com/highlight/detail?id=2562059620","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562059620?lang=en_us&edition=fundamental","pubTime":"2025-08-28 22:57","pubTimestamp":1756393035,"startTime":"0","endTime":"0","summary":"BRIEF-China Medical System Receives Approval For Clinical Trials Of Jak1 Inhibitor POVORCITINIBAug 28 (Reuters) - China Medical System Holdings Ltd 0867.HK:APPROVAL FOR CLINICAL TRIALS OF JAK1 INHIBIT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nFWN3UK0VQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BYV24P56.USD","SG9999004220.SGD","SG9999015952.SGD","00867","IE00BMCWC346.EUR","SG9999015986.USD","LU2488822045.USD","SG9999015978.USD","BK1593","IE00BVYPNP33.GBP","IE00BVYPNQ40.USD","IE00BGHQDM52.EUR","BK1191","SG9999015945.SGD"],"gpt_icon":0},{"id":"2562746056","title":"Modern Dental Group Ltd. Announces Interim Dividend of HKD 0.107 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2562746056","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562746056?lang=en_us&edition=fundamental","pubTime":"2025-08-28 22:49","pubTimestamp":1756392582,"startTime":"0","endTime":"0","summary":"Modern Dental Group Ltd. announced an interim dividend of HKD 0.107 per share for the six months ended 30 June 2025. The dividend does not require shareholder approval. The payment date is set for 9 October 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Modern Dental Group Ltd. published the original content used to generate this news brief on August 28, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nNDL4PJDX2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03600","BK1583","BK1593","BK1100"],"gpt_icon":0},{"id":"2562561940","title":"Modern Dental Group H1 Gross Margin 54.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562561940","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562561940?lang=en_us&edition=fundamental","pubTime":"2025-08-28 22:41","pubTimestamp":1756392067,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nPLX49C22D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1100","03600","BK1583","BK1593"],"gpt_icon":0},{"id":"2562056193","title":"Modern Dental Group Ltd - Declared Interim Dividend of HK10.7 Cents per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2562056193","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562056193?lang=en_us&edition=fundamental","pubTime":"2025-08-28 22:41","pubTimestamp":1756392067,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nPLX49C22D:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03600","BK1593","BK1583","BK1100"],"gpt_icon":0},{"id":"2562056192","title":"Modern Dental Group H1 Adjusted Ebitda Margin 24.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562056192","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562056192?lang=en_us&edition=fundamental","pubTime":"2025-08-28 22:41","pubTimestamp":1756392067,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nPLX49C22D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1593","BK1583","03600","BK1100"],"gpt_icon":0},{"id":"1100103646","title":"CMS (00867): Innovative Oral Small Molecule JAK1 Inhibitor Povorcitinib Receives Clinical Trial Approval for Vitiligo and Hidradenitis Suppurativa Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=1100103646","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100103646?lang=en_us&edition=fundamental","pubTime":"2025-08-28 20:43","pubTimestamp":1756384997,"startTime":"0","endTime":"0","summary":"CMS (00867) announced that its subsidiary DeMai Pharmaceuticals Limited (DeMai Pharmaceuticals, an innovative pharmaceutical company focused on dermatological health that is applying for independent...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQDM52.EUR","06978","IE00BVYPNQ40.USD","BK1593","BK1161","IE00BVYPNP33.GBP","IE00BMCWC346.EUR","BK1191","159992","BK1574","00867","SG9999004220.SGD","IE00BYV24P56.USD","LU2488822045.USD","SG9999015945.SGD","SG9999015978.USD","SG9999015986.USD","SG9999015952.SGD"],"gpt_icon":0},{"id":"2562034987","title":"China Medical System Holdings Limited Approval of Clinical Trials for Vitiligo and Hidradenitis Suppurativa Indications of Povorcitinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2562034987","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562034987?lang=en_us&edition=fundamental","pubTime":"2025-08-28 20:14","pubTimestamp":1756383278,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nTUEP47DZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2488822045.USD","BK1191","IE00BVYPNQ40.USD","BK1593","SG9999004220.SGD","IE00BGHQDM52.EUR","IE00BYV24P56.USD","SG9999015986.USD","IE00BMCWC346.EUR","SG9999015945.SGD","SG9999015978.USD","IE00BVYPNP33.GBP","00867","SG9999015952.SGD"],"gpt_icon":0},{"id":"2562403462","title":"Dermavon Holdings, a Subsidiary of China Medical System, Gains Approval for Clinical Trials on Innovative JAK1 Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2562403462","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562403462?lang=en_us&edition=fundamental","pubTime":"2025-08-28 20:09","pubTimestamp":1756382954,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited has announced that its subsidiary, Dermavon Holdings Limited, has received approval from the National Medical Products Administration of the People's Republic of China to conduct clinical trials for povorcitinib. This innovative oral small-molecule JAK1 inhibitor will be tested for the treatment of non-segmental vitiligo and moderate to severe hidradenitis suppurativa. Dermavon, an innovative pharmaceutical company specializing in skin health, is actively preparing to initiate these clinical trials and aims to launch the product as soon as possible. Dermavon is also pursuing an independent listing on the Main Board of The Stock Exchange of Hong Kong Limited, further amplifying its potential impact in the pharmaceutical industry.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nNDL7wfxq5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BYV24P56.USD","IE00BVYPNQ40.USD","IE00BMCWC346.EUR","IE00BVYPNP33.GBP","LU2488822045.USD","SG9999015986.USD","BK1191","SG9999004220.SGD","SG9999015952.SGD","IE00BGHQDM52.EUR","00867","SG9999015978.USD","SG9999015945.SGD","BK1593"],"gpt_icon":0},{"id":"2562034336","title":"China Medical System Holdings Ltd - Nmpa Approves Clinical Trials for Povorcitinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2562034336","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562034336?lang=en_us&edition=fundamental","pubTime":"2025-08-28 20:05","pubTimestamp":1756382718,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nFWN3UK0VQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BVYPNP33.GBP","LU2488822045.USD","IE00BGHQDM52.EUR","SG9999015986.USD","SG9999015945.SGD","BK1593","IE00BYV24P56.USD","IE00BMCWC346.EUR","SG9999015952.SGD","BK1191","00867","IE00BVYPNQ40.USD","SG9999004220.SGD","SG9999015978.USD"],"gpt_icon":0},{"id":"1122283967","title":"JPMorgan Increases Holdings in ANGELALIGN (06699) by 493,200 Shares at Approximately HK$67.58 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1122283967","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122283967?lang=en_us&edition=fundamental","pubTime":"2025-08-28 19:13","pubTimestamp":1756379587,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, JPMorgan increased its holdings in ANGELALIGN (06699) by 493,200 shares on August 25, at a price of HK$67.5779 per share, with a total...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1914381329.SGD","LU1629891620.HKD","BK4585","LU2357305700.SGD","LU2237443465.HKD","LU0234572021.USD","LU0868494708.USD","LU1084165304.USD","IE00BJTD4V19.USD","LU0149725797.USD","LU0943347566.SGD","IE00BWXC8680.SGD","IE00BYXW3230.USD","IE00BBT3K403.USD","LU0971096721.USD","LU1244550494.USD","LU2213496289.HKD","IE00B1BXHZ80.USD","LU2592432038.USD","LU0640476718.USD","IE00B1XK9C88.USD","LU1119994496.HKD","LU0689472784.USD","LU0320765646.SGD","LU0238689110.USD","LU0215105999.USD","LU1366192091.USD","LU1280957306.USD","LU2456880835.USD","IE00BFXG1179.USD","IE0034235303.USD","LU0882574139.USD","LU0006306889.USD","LU1496350171.SGD","LU0106831901.USD","LU0683600562.USD","LU0208291251.USD","LU0203345920.USD","IE00BLSP4452.SGD","LU2417539215.USD","LU0267386448.USD","LU0211327993.USD","LU2430703178.SGD","LU0251132253.USD","LU2237443978.SGD","LU0976567544.SGD","BK4581","LU2746668974.SGD","LU2505996509.AUD","LU0310799852.SGD","LU0496365809.HKD","BK4566","IE00B3S45H60.SGD","LU0820561909.HKD","LU1670628061.USD","LU0211326839.USD","LU1363072403.SGD","LU0323591593.USD","LU1261432733.SGD","LU0345770308.USD","IE0034235188.USD","LU0345769631.USD","IE00BLSP4239.USD","LU2430703095.HKD","IE0034235295.USD","LU0345770993.USD","LU1894683348.USD","LU1496350502.SGD","IE00BZ1G4Q59.USD","LU1720051108.HKD","LU2236285917.USD","06699","BK4534","LU0820561818.USD","LU1894683264.USD","LU2054465674.USD","LU1670627923.USD","LU1917777945.USD","LU2106854487.HKD","LU0256863811.USD","LU2462157665.USD","LU1551013342.USD","BK1593","LU1974910355.USD","IE00BN8TJ469.HKD","LU0211331839.USD","LU2237443549.SGD","LU0048584097.USD","LU0211326755.USD","LU2237443622.USD","LU1244550577.SGD","LU2430703251.USD","LU1162221912.USD","LU2242649171.HKD","LU1064131342.USD","LU0070302665.USD","LU0211328371.USD","LU2505996681.GBP","BK4207","LU2746668461.USD","IE00BJLML261.HKD","BK4533","BK4550","LU1032466523.USD","LU2237443895.HKD","LU2264538146.SGD","LU2756315318.SGD","LU0203347892.USD","LU0787776722.HKD","LU1267930490.SGD","LU2237443382.USD","SG9999002224.SGD","IE00BDRTCR15.USD","SG9999002232.USD","IE00BHPRN162.USD","LU1145028129.USD","LU2552382058.USD","LU2756315664.SGD","BK4504","BK1583","IE00BDCRKT87.USD","LU1244550221.USD","LU1988902786.USD","LU2552382215.SGD","LU0942090050.USD","LU1720051017.SGD","BK1587","LU2023250843.SGD","BK1100","LU1668664300.SGD","LU0320765489.SGD","LU1551013425.SGD","IE00BKVL7J92.USD","IE00BKDWB100.SGD","LU0106261372.USD","BK4588","IE000M9KFDE8.USD","LU0820562030.AUD","BK4516","LU0964807845.USD","LU1548497426.USD","IE00B775SV38.USD","LU0868494617.USD","LU0345769128.USD","LU2023250504.SGD","LU2023250330.USD","IE00BJTD4N35.SGD","LU2552382132.HKD","LU0170899867.USD","LU0417517546.SGD"],"gpt_icon":0},{"id":"1177981403","title":"China Merchants Bank International Raises ANGELALIGN (06699) Target Price to HK$86.47, Overseas Business Expansion Drives Revenue Growth, Maintains \"Buy\" Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1177981403","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177981403?lang=en_us&edition=fundamental","pubTime":"2025-08-28 17:30","pubTimestamp":1756373452,"startTime":"0","endTime":"0","summary":"China Merchants Bank International has released a research report stating that ANGELALIGN (06699) delivered strong first-half performance with revenue growing 33% year-over-year, primarily driven by...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1100","BK1587","BK1583","06699"],"gpt_icon":0},{"id":"1177149496","title":"Hong Kong Stock Alert | FOSUN PHARMA (02196) Surges Nearly 5% in Early Trading as Interim Net Profit Jumps Nearly 40% YoY, Grants Overseas Development Rights to Sitala","url":"https://stock-news.laohu8.com/highlight/detail?id=1177149496","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177149496?lang=en_us&edition=fundamental","pubTime":"2025-08-28 09:50","pubTimestamp":1756345822,"startTime":"0","endTime":"0","summary":"FOSUN PHARMA (02196) climbed nearly 5% during early trading hours. As of press time, the stock was up 3.95% to HK$22.08, with trading volume reaching HK$107 million. On the news front, FOSUN PHARMA...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0012","BK1191","BK0028","BK0096","02196","BK1515","600196","BK0183","BK0239","BK0060","BK0196","BK1593","BK0187","BK0175"],"gpt_icon":0},{"id":"1187644871","title":"LAI FUNG HOLD (01125) Shareholders Transfer Shares from ICBC Asia Securities to Bank of China (Hong Kong), Transfer Value Reaches HK$32.18 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1187644871","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187644871?lang=en_us&edition=fundamental","pubTime":"2025-08-28 08:26","pubTimestamp":1756340809,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on August 27, shareholders of LAI FUNG HOLD (01125) transferred shares from ICBC Asia Securities to Bank of China (Hong Kong), with a...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03143","IE00BQJZWZ67.USD","BK0188","601988","BK1560","BK1521","BK1231","LU0651946864.USD","BK0278","BK0012","BK0183","01125","IE00BWDBJ730.SGD","LU0348805143.USD","LU1282651121.HKD","SG9999006597.SGD","IE00B19Z5X02.USD","LU1497734951.SGD","LU0651947912.USD","LU2097828631.EUR","SG9999001093.SGD","BK1593","LU1497733557.USD","BK0015","LU1515016050.SGD","LU1048588211.SGD","LU1224444064.USD","BK1240","LU0293314216.USD","LU0072462343.USD","LU0588546209.SGD","LU1497733631.SGD","161027","LU2097828474.EUR","LU2097828714.EUR","LU1522347837.USD","LU1634259557.SGD","LU1282651048.USD","LU0307460666.USD","LU2097828805.USD","BK0028","LU1634259391.SGD","LU1051768304.USD","03988","LU1051769294.HKD","LU2097828557.USD"],"gpt_icon":0},{"id":"1116994085","title":"Goldman Sachs Raises ANGELALIGN (06699) Target Price to HK$81.3 with \"Buy\" Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1116994085","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116994085?lang=en_us&edition=fundamental","pubTime":"2025-08-27 14:52","pubTimestamp":1756277543,"startTime":"0","endTime":"0","summary":"Goldman Sachs released a research report stating that it has raised ANGELALIGN's (06699) target price from HK$78.8 to HK$81.3 using the Sum of The Parts (SOTP) valuation method, maintaining a \"Buy\"...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836757.USD","IE00BFXG1179.USD","BK1587","LU2471134523.USD","LU2750360997.AUD","LU1894683348.USD","LU2237443382.USD","BK4504","IE0004091025.USD","IE0004086264.USD","LU2471134952.CNY","LU2237443622.USD","BK4127","LU1868836914.USD","LU2237438978.USD","LU0106831901.USD","LU2750360641.GBP","LU1668664300.SGD","06699","LU2237443978.SGD","BK1100","LU0061475181.USD","IE0002270589.USD","LU2237443465.HKD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","BK4533","BK4588","LU2471134879.HKD","LU2237443549.SGD","BK4516","IE00BSNM7G36.USD","LU1868837300.USD","LU2471134796.USD","LU1791807156.HKD","BK4585","LU0096364046.USD","LU2237443895.HKD","LU0251142724.SGD","LU1894683264.USD","BK4550","LU0742534661.SGD","IE0034235188.USD","LU1868836591.USD","LU0048573561.USD","BK4552","BK1593","LU1868837136.USD","BK1583","LU0251131958.USD"],"gpt_icon":0},{"id":"1176183750","title":"FOSUN PHARMA (02196): Drug Registration Application for Vincristine Sulfate Injection Accepted by National Medical Products Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=1176183750","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176183750?lang=en_us&edition=fundamental","pubTime":"2025-08-26 21:14","pubTimestamp":1756214074,"startTime":"0","endTime":"0","summary":"FOSUN PHARMA (02196) announced that its controlling subsidiary Gismer (Wuhan) Pharmaceutical Co., Ltd. has recently received acceptance from the National Medical Products Administration for its drug...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0175","BK0239","BK0187","BK1515","BK0060","BK0096","BK1593","BK1191","BK0196","BK0183","BK0028","600196","BK0012","02196"],"gpt_icon":0},{"id":"2562664739","title":"Press Release: Fosun Pharma Announces 2025 Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2562664739","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562664739?lang=en_us&edition=fundamental","pubTime":"2025-08-26 20:42","pubTimestamp":1756212120,"startTime":"0","endTime":"0","summary":"SHANGHAI, Aug. 26, 2025 /PRNewswire/ -- On August 26, 2025, Shanghai Fosun Pharmaceutical  Co., Ltd. , a leading innovation-driven global healthcare company, announced its operating performance for the first half of 2025 .During the Reporting Period, Fosun Pharma continued to push forward its innovation transformation and the development and commercialization of innovative products, enhance global operations, and further strengthened its global commercialization capacity and infrastructure. Fosun Pharma also deepened its digitalization and AI strategy, progressively building a digital and intelligent system covering R&D, operation, and product application.During the Reporting Period, Fosun Pharma's total R&D expenditure amounted to RMB 2,584 million, of which R&D expenses amounted to RMB 1,717 million. The R&D expenditure in the pharmaceutical manufacturing segment amounted to RMB 2,295 million, accounting for 16.51 % of pharmaceutical business revenue. In particular, the R&D expenses ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1230","BK0188","BK0175","BK0239","BK0187","BK1515","BK0060","BK0096","BK1593","BK1191","BK0196","00656","BK0183","BK0028","600196","BK0012","02196"],"gpt_icon":0},{"id":"1199689359","title":"FOSUN PHARMA (02196) Reports 2025 Interim Results with Improved Operating Cash Flow and Continued Innovation Transformation","url":"https://stock-news.laohu8.com/highlight/detail?id=1199689359","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199689359?lang=en_us&edition=fundamental","pubTime":"2025-08-26 20:15","pubTimestamp":1756210503,"startTime":"0","endTime":"0","summary":"On August 26, FOSUN PHARMA (600196.SH, 02196) officially released its 2025 interim financial results. The data shows that during the reporting period, the Group achieved operating revenue of 19.514...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159399","BK0183","BK0188","BK0239","BK0196","600196","BK1191","BK0012","BK0028","BK1593","BK0175","02196","BK0187","BK0096","BK1515","BK0060"],"gpt_icon":0},{"id":"1191905201","title":"AH Stock Statistics | August 26","url":"https://stock-news.laohu8.com/highlight/detail?id=1191905201","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191905201?lang=en_us&edition=fundamental","pubTime":"2025-08-26 16:17","pubTimestamp":1756196257,"startTime":"0","endTime":"0","summary":"As of the close on August 26, NE Electric (00042), Holly Futures (03678), and Andre Juice (02218) ranked as the top three AH stocks by premium rate, with premiums of 757.14%, 249.45%, and 240.33%...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1582","LU0979878070.USD","BK1161","LU0228659784.USD","LU1188198961.HKD","LU0269904917.USD","601633","IE00BMCWC346.EUR","LU0456846285.SGD","LU2348774022.SGD","IE00B031J352.USD","LU0359201885.HKD","BK1594","03606","LU1868837565.USD","LU0039217434.USD","LU0096374516.USD","LU2357125470.USD","BK1539","LU2097828557.USD","LU1960683339.HKD","01108","LU0540923850.HKD","BK1514","01618","LU1211504680.USD","IE00B543WZ88.USD","LU0797268264.HKD","BK1546","LU1242518931.SGD","LU0531971595.HKD","LU0791591158.USD","LU0449515922.USD","LU0211977185.USD","02039","SG9999015978.USD","LU0345780281.USD","LU0594300419.USD","LU0348735423.USD","BK1171","SG9999014674.SGD","IE00B0169L03.USD","BK1206","LU0072913022.USD","LU1328277881.USD","LU1282649067.USD","LU0561508036.HKD","LU1282649810.SGD","LU0417516738.SGD","LU0456827905.SGD","LU1961090484.USD","LU2449936058.SGD","LU1048596156.SGD","SG9999012744.USD","LU2097828631.EUR","LU0054450605.USD","LU0502904849.HKD","BK1191","LU1675838814.USD","LU1808992512.USD","LU0594300179.USD","LU1242518857.USD","BK1148","BK1506","LU0821914370.USD","LU0823039010.USD","LU1224709979.USD","002594","LU1880383440.USD","LU1861219969.SGD","LU1880383366.USD","BK1564","HYDD.SI","LU0449509016.USD","LU0405327148.USD","LU0320764599.SGD","LU1105468828.SGD","LU2506951792.HKD","SG9999015952.SGD","BK1551","LU0163747925.USD","BK1205","LU0588545730.USD","LU0289739343.SGD","IE0008369823.USD","LU0463099449.HKD","IE00B29SXG58.USD","IE0032431581.USD","LU0052750758.USD","LU1064130708.USD","IE00B031HY20.USD","BK1231","06680","LU0505663152.USD","LU0828237940.HKD","BK1149","IE00B3M56506.USD","BK1509","BK1507","IE00B5MMRT66.SGD","BK1214","SG9999015945.SGD","SG9999006514.SGD","LU0214875030.USD","LU0348827113.USD","LU0589944569.HKD","BK1198","BK1154","BYDDY","HK0000320223.HKD","LU1720050803.USD","BK1523","HK0000252160.HKD","LU0287142896.SGD","LU0061477393.USD","LU1366334651.USD","BK1237","LU0488056044.USD","IE0031814852.USD","LU0708995583.HKD","SG9999002950.SGD","LU0823414478.USD","01812","SG9999012710.SGD","IE00BYV24P56.USD","BK1544","LU1770034418.SGD","LU0175139822.USD","02333","LU1813983027.USD","LU0455707207.USD","LU1251922891.USD","BK1560","LU0543330566.HKD","LU1046422090.SGD","LU0289960550.SGD","BK1202","BK1110","LU1993786604.SGD","LU2097828805.USD","LU1152091754.HKD","03347","LU2778985437.USD","HK0000306685.HKD","BK1183","BK1105","BK1522","LU2097828474.EUR","LU0043850808.USD","BK1568","399300","LU0828237510.HKD","LU2148510915.USD","BK1584","LU0231483743.USD","82333","IE00BZ08YS42.EUR","LU2249611893.SGD","LU0868486357.SGD","LU0516422952.EUR","SG9999015986.USD","LU0254981946.USD","LU0431992006.USD","01033","SG9999004220.SGD","LU0871576103.HKD","LU0051755006.USD","LU0067412154.USD","00358","01349","LU0856984785.SGD","BK1521","LU1719994722.HKD","LU2399975544.HKD","LU0084288322.USD","LU0862451753.SGD","BK1583","LU0823038988.USD","LU0588546209.SGD","SG9999002463.SGD","BK1565","02727","LU0164872284.USD","00916","LU0143863198.USD","02359","LU0173614495.USD","LU0289961442.SGD","BK1184","LU0634319403.HKD","LU0143863784.USD","LU2153592121.USD","LU0737861699.HKD","LU0828238088.HKD","LU0165289439.USD","LU0918141887.USD","IE0008368742.USD","LU0511384066.AUD","02465","LU1064131003.USD","BK1144","LU0918141705.HKD","LU2125910500.SGD","LU0259732245.USD","LU0588545904.SGD","BK1119","LU1807302812.USD","LU0501845795.SGD","LU0650527681.SGD","LU0348805143.USD","HK0000306701.USD","LU0348825331.USD","IE00BZ08YT58.USD","LU1366334578.USD","LU0359202008.SGD","03750","BK1558","LU0886674414.USD","LU0314109678.HKD","159982","02338","BK1513","LU2226246903.HKD","LU0244354667.USD","BK1593","LU1794554557.SGD","00300","02628","LU2097828714.EUR","LU0640798160.USD","LU1023057109.AUD","LU0823426308.USD","LU0229945570.USD","03678","LU0384037296.USD","LU1282649141.HKD","LU0405327494.USD","SG9999006597.SGD","LU0516423091.SGD","BK1592","LU0516422440.USD","LU1152091168.USD","BK1554","IE00BF5LJ272.USD","01766","LU0593848301.USD","02899","SG9999012736.USD","06869","LU0359201612.USD","LU1868837722.USD","BK1141","LU0605514214.HKD","LU1303224171.USD","LU0865486749.SGD","02238","LU0140636845.USD","LU0228367735.SGD","LU2294711713.HKD","BK1505","LU0890818403.SGD","BK1562","LU1282648689.USD","SG9999002828.SGD","LU0326950275.SGD","LU0823040885.USD","03968","BK1576","HK0000252152.HKD","LU0049853897.USD","BK1550","LU0819121731.USD","LU1504937902.USD","LU0327786744.USD","LU1226287529.USD","GWLLY","LU0880133367.SGD","BK1223","LU2476274720.SGD","LU0048580855.USD","LU2242644610.SGD","SG9999012728.SGD","01276","HK0000320264.USD","LU2543165471.USD","02218","SG9999001226.SGD","LU1008478684.HKD","LU0164865239.USD","IE0034224299.USD","06826","LU2360107325.USD","LU0117841782.USD","LU1655091616.SGD","IE00BZ08YR35.GBP","81211","LU0823426480.USD","LU0531970944.HKD","LU0823414551.USD","LU0348814723.USD","LU0315178854.USD","LU0648948544.HKD","LU0307460666.USD","LU2476274308.USD","06178","LU2045819591.USD","LU0819123356.HKD","LU0417516902.SGD","LU0516422366.SGD","BK1610","LU0348788117.USD","00042","LU0572944931.SGD","LU0181495838.USD","LU0106959298.USD","00187","LU1861214812.USD","LU0106252389.USD","LU0469268626.HKD","LU0348816934.USD","BK1147","LU0791590937.USD","IE00BD6J9T35.USD","LU0370786039.SGD","01211","BK1540","IE00BGHQDM52.EUR","01288","IE00BVYPNP33.GBP","LU1688375341.USD","LU0509642566.USD","HK0000500386.USD","IE00BVYPNQ40.USD","LU2039709279.SGD","LU1115378108.SGD","LU0516423174.USD","LU1831875114.USD","LU0588545490.SGD","LU0315179316.USD","BK1116","LU0345780521.USD","LU1868838027.USD","03143"],"gpt_icon":1}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":83,"code":"91000000","status":"200"}]}}